Comparing Alterations of Blood Glucose Level in type II Diabetic Pa-tients Taking Metformin and Withhold of Metformin on the Morning of Coronary Artery Bypass Graft Surgery

Introduction & Objective: In the context effect of metformin in patients with acute coronary syndrome, available evidence supports cardiac effect. Yet, there is doubt about continuation or discontinuation of metformin before major surgery. The aim of the present study is to determine the efficac...

Full description

Bibliographic Details
Main Authors: M. Tarbiat, S.A Aghaee Meybodi, M. Farhadian
Format: Article
Language:fas
Published: Hamadan University of Medical Sciences 2016-09-01
Series:پزشکی بالینی ابن سینا
Subjects:
Online Access:http://sjh.umsha.ac.ir/article-1-1171-en.html
_version_ 1818398729890168832
author M. Tarbiat
S.A Aghaee Meybodi
M. Farhadian
author_facet M. Tarbiat
S.A Aghaee Meybodi
M. Farhadian
author_sort M. Tarbiat
collection DOAJ
description Introduction & Objective: In the context effect of metformin in patients with acute coronary syndrome, available evidence supports cardiac effect. Yet, there is doubt about continuation or discontinuation of metformin before major surgery. The aim of the present study is to determine the efficacy of continuing metformin in plasma glucose, renal function index, arterial PH in type II diabetic patients after coronary artery bypass graft surgery.     Materials & Methods: In this clinical-experimental study, 90 type II diabetic patients with ASA class II admitted for CABG surgery in Hamadan Ekbatan Hospital were enrolled  in the study in 2014 and were randomly assigned to two groups , one group treated with insulin and continued metformin and the other group treated with insulin and discontinued metformin.In the beginning indicators such as age, sex, body mass index (BMI) were compared which were not significantly different in the two groups. Then, other parameters such as blood glucose, BUN, Cr, arterial blood PH, cardiac arrhythmia and need for inotrope were compared. Used inotropes in this study included dopamine, dobutamine, epinephrine, norepinephrine, milrinon to achieve  systolic blood presser pressure over 100mmHg. Results: Average plasma BUN after surgery and one day after surgery in the group who discontinued metformin significantly were higher compared with the metformin group, but no differences were observed in average plasma BUN in  the 2nd and 3rd days after surgery in the two groups. During 3 days after surgery, average plasma creatinine was significantly lower in metformin group compared to non- metformin group. Although there was  no difference between the  two groups in pH parameter before surgery but in the metformin group, average pH was lower than non-metformin group after surgery. Before and 3 days after surgery mean blood glucose level was not significantly different between the two groups. During surgery, average need for inotrope in metformin group equaled 1.57 person and in non- metformin group equaled 1.05 person showing no significant difference in demography. In the both groups, not only before surgery, but also after surgery there was no cardiac arrhythmia. Also, the need for inotrope duration and tracheal intubation duration in ICU were not significantly different. Conclusion: Although serum glucose level of patients did not change, continuation and discontinuation of metformin in patients with CABG surgery was concomitant with elevated BUN and Cr. Level and decrease of pH on the 1st and 2nd days after surgery. Noticeably, BUN and Cr. Fluctuation in patients who continued metformin, were significantly lower, but  in the two groups these  values were  reversible and return to normal range in pending several days after surgery. Prescription of this drug did not increase the need for cardiac inotrope and risk of incidence of arrhythmia after surgery.
first_indexed 2024-12-14T07:09:25Z
format Article
id doaj.art-3ce68e74d6b44adf95e4a8e1392bd1e5
institution Directory Open Access Journal
issn 2588-722X
2588-7238
language fas
last_indexed 2024-12-14T07:09:25Z
publishDate 2016-09-01
publisher Hamadan University of Medical Sciences
record_format Article
series پزشکی بالینی ابن سینا
spelling doaj.art-3ce68e74d6b44adf95e4a8e1392bd1e52022-12-21T23:12:01ZfasHamadan University of Medical Sciencesپزشکی بالینی ابن سینا2588-722X2588-72382016-09-01232110117Comparing Alterations of Blood Glucose Level in type II Diabetic Pa-tients Taking Metformin and Withhold of Metformin on the Morning of Coronary Artery Bypass Graft SurgeryM. Tarbiat0S.A Aghaee Meybodi1M. Farhadian2 Introduction & Objective: In the context effect of metformin in patients with acute coronary syndrome, available evidence supports cardiac effect. Yet, there is doubt about continuation or discontinuation of metformin before major surgery. The aim of the present study is to determine the efficacy of continuing metformin in plasma glucose, renal function index, arterial PH in type II diabetic patients after coronary artery bypass graft surgery.     Materials & Methods: In this clinical-experimental study, 90 type II diabetic patients with ASA class II admitted for CABG surgery in Hamadan Ekbatan Hospital were enrolled  in the study in 2014 and were randomly assigned to two groups , one group treated with insulin and continued metformin and the other group treated with insulin and discontinued metformin.In the beginning indicators such as age, sex, body mass index (BMI) were compared which were not significantly different in the two groups. Then, other parameters such as blood glucose, BUN, Cr, arterial blood PH, cardiac arrhythmia and need for inotrope were compared. Used inotropes in this study included dopamine, dobutamine, epinephrine, norepinephrine, milrinon to achieve  systolic blood presser pressure over 100mmHg. Results: Average plasma BUN after surgery and one day after surgery in the group who discontinued metformin significantly were higher compared with the metformin group, but no differences were observed in average plasma BUN in  the 2nd and 3rd days after surgery in the two groups. During 3 days after surgery, average plasma creatinine was significantly lower in metformin group compared to non- metformin group. Although there was  no difference between the  two groups in pH parameter before surgery but in the metformin group, average pH was lower than non-metformin group after surgery. Before and 3 days after surgery mean blood glucose level was not significantly different between the two groups. During surgery, average need for inotrope in metformin group equaled 1.57 person and in non- metformin group equaled 1.05 person showing no significant difference in demography. In the both groups, not only before surgery, but also after surgery there was no cardiac arrhythmia. Also, the need for inotrope duration and tracheal intubation duration in ICU were not significantly different. Conclusion: Although serum glucose level of patients did not change, continuation and discontinuation of metformin in patients with CABG surgery was concomitant with elevated BUN and Cr. Level and decrease of pH on the 1st and 2nd days after surgery. Noticeably, BUN and Cr. Fluctuation in patients who continued metformin, were significantly lower, but  in the two groups these  values were  reversible and return to normal range in pending several days after surgery. Prescription of this drug did not increase the need for cardiac inotrope and risk of incidence of arrhythmia after surgery.http://sjh.umsha.ac.ir/article-1-1171-en.htmlcoronary artery baypasscreatinindiabetes mellitusmetformin
spellingShingle M. Tarbiat
S.A Aghaee Meybodi
M. Farhadian
Comparing Alterations of Blood Glucose Level in type II Diabetic Pa-tients Taking Metformin and Withhold of Metformin on the Morning of Coronary Artery Bypass Graft Surgery
پزشکی بالینی ابن سینا
coronary artery baypass
creatinin
diabetes mellitus
metformin
title Comparing Alterations of Blood Glucose Level in type II Diabetic Pa-tients Taking Metformin and Withhold of Metformin on the Morning of Coronary Artery Bypass Graft Surgery
title_full Comparing Alterations of Blood Glucose Level in type II Diabetic Pa-tients Taking Metformin and Withhold of Metformin on the Morning of Coronary Artery Bypass Graft Surgery
title_fullStr Comparing Alterations of Blood Glucose Level in type II Diabetic Pa-tients Taking Metformin and Withhold of Metformin on the Morning of Coronary Artery Bypass Graft Surgery
title_full_unstemmed Comparing Alterations of Blood Glucose Level in type II Diabetic Pa-tients Taking Metformin and Withhold of Metformin on the Morning of Coronary Artery Bypass Graft Surgery
title_short Comparing Alterations of Blood Glucose Level in type II Diabetic Pa-tients Taking Metformin and Withhold of Metformin on the Morning of Coronary Artery Bypass Graft Surgery
title_sort comparing alterations of blood glucose level in type ii diabetic pa tients taking metformin and withhold of metformin on the morning of coronary artery bypass graft surgery
topic coronary artery baypass
creatinin
diabetes mellitus
metformin
url http://sjh.umsha.ac.ir/article-1-1171-en.html
work_keys_str_mv AT mtarbiat comparingalterationsofbloodglucoselevelintypeiidiabeticpatientstakingmetforminandwithholdofmetforminonthemorningofcoronaryarterybypassgraftsurgery
AT saaghaeemeybodi comparingalterationsofbloodglucoselevelintypeiidiabeticpatientstakingmetforminandwithholdofmetforminonthemorningofcoronaryarterybypassgraftsurgery
AT mfarhadian comparingalterationsofbloodglucoselevelintypeiidiabeticpatientstakingmetforminandwithholdofmetforminonthemorningofcoronaryarterybypassgraftsurgery